(Q38391526)

2 September 2017

1 reference

title

Advances in allergen immunotherapy: aiming for complete tolerance to allergens (English)

1 reference

2 September 2017

1 reference

1

Cezmi A Akdis

1 reference

2 September 2017

2

Mübeccel Akdis

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 March 2015

1 reference

Science Translational Medicine

2 September 2017

published in

1 reference

2 September 2017

volume

7

1 reference

2 September 2017

issue

280

1 reference

2 September 2017

page(s)

280ps6

1 reference

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Immunotherapy: what lies beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

The special challenge of nonadherence with sublingual immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Patient adherence to allergy immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

The 3 major types of innate and adaptive cell-mediated effector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Role of interleukin 10 in specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Early improvement in basophil sensitivity predicts symptom relief with grass pollen immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Enhanced innate type 2 immune response in peripheral blood from patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Immunoglobulin G4: an odd antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Immune mechanisms of sublingual immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Prophylactic use of sublingual allergen immunotherapy in high-risk children: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Bypassing IgE and targeting T cells for specific immunotherapy of allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Prolonged antigen-exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Comparing safety of abrasion and tape-stripping as skin preparation in allergen-specific epicutaneous immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Modulation of allergen-specific T-lymphocyte function by virus-like particles decorated with HLA class II molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

A chimeric human-cat fusion protein blocks cat-induced allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Asthma phenotypes: the evolution from clinical to molecular approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

Use of omalizumab to improve desensitization safety in allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA7390

10.1126/SCITRANSLMED.AAA7390

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference